West Coast Financial LLC boosted its stake in shares of Maximus, Inc. (NYSE:MMS – Free Report) by 1.7% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 90,495 shares of the health services provider’s stock after acquiring an additional 1,552 shares during the quarter. West Coast Financial LLC’s holdings in Maximus were worth $6,755,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
A number of other large investors have also bought and sold shares of the stock. V Square Quantitative Management LLC bought a new position in shares of Maximus in the third quarter worth approximately $25,000. Eastern Bank purchased a new stake in shares of Maximus during the fourth quarter worth about $29,000. GAMMA Investing LLC boosted its holdings in Maximus by 150.6% in the third quarter. GAMMA Investing LLC now owns 862 shares of the health services provider’s stock valued at $80,000 after acquiring an additional 518 shares in the last quarter. Quarry LP grew its holdings in shares of Maximus by 48.0% during the 3rd quarter. Quarry LP now owns 1,017 shares of the health services provider’s stock worth $95,000 after acquiring an additional 330 shares during the period. Finally, Ariadne Wealth Management LP bought a new position in shares of Maximus in the 2nd quarter worth about $90,000. 97.21% of the stock is owned by hedge funds and other institutional investors.
Maximus Price Performance
Shares of NYSE:MMS opened at $77.77 on Thursday. Maximus, Inc. has a 1-year low of $69.72 and a 1-year high of $93.97. The company has a debt-to-equity ratio of 0.59, a current ratio of 1.49 and a quick ratio of 1.49. The company has a market capitalization of $4.69 billion, a P/E ratio of 15.55 and a beta of 0.73. The firm’s 50 day simple moving average is $76.12 and its two-hundred day simple moving average is $84.70.
Maximus Announces Dividend
Insider Transactions at Maximus
In related news, CEO Bruce Caswell bought 3,500 shares of the business’s stock in a transaction on Tuesday, December 17th. The shares were bought at an average price of $70.64 per share, for a total transaction of $247,240.00. Following the completion of the purchase, the chief executive officer now directly owns 275,929 shares of the company’s stock, valued at approximately $19,491,624.56. This trade represents a 1.28 % increase in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, insider Michelle F. Link sold 2,208 shares of the stock in a transaction on Tuesday, December 3rd. The shares were sold at an average price of $73.83, for a total value of $163,016.64. Following the sale, the insider now owns 6,567 shares of the company’s stock, valued at approximately $484,841.61. This represents a 25.16 % decrease in their position. The disclosure for this sale can be found here. Over the last three months, insiders have bought 7,063 shares of company stock valued at $502,017. 1.40% of the stock is currently owned by insiders.
Analysts Set New Price Targets
MMS has been the topic of a number of recent analyst reports. StockNews.com cut shares of Maximus from a “buy” rating to a “hold” rating in a report on Friday, December 27th. Raymond James raised Maximus from a “market perform” rating to an “outperform” rating and set a $90.00 price objective for the company in a report on Thursday, January 2nd.
Check Out Our Latest Analysis on Maximus
About Maximus
Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.
Further Reading
- Five stocks we like better than Maximus
- Dividend Screener: How to Evaluate Dividend Stocks Before Buying
- 3 Cheap Small-Cap Banks for Dividend Growth Investors
- Conference Calls and Individual Investors
- 3 Defensive Stocks Analysts Are Bullish on to Kick Off the Year
- 3 Natural Gas Stocks That Offer Great Dividend Yields
- Vistra Corp: Could 2025 Continue Its Streak of Outperformance?
Want to see what other hedge funds are holding MMS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Maximus, Inc. (NYSE:MMS – Free Report).
Receive News & Ratings for Maximus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Maximus and related companies with MarketBeat.com's FREE daily email newsletter.